These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29020088)

  • 1. Expression level of human TLR4 rather than sequence is the key determinant of LPS responsiveness.
    Hajjar AM; Ernst RK; Yi J; Yam CS; Miller SI
    PLoS One; 2017; 12(10):e0186308. PubMed ID: 29020088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
    Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
    Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes.
    Shibata T; Motoi Y; Tanimura N; Yamakawa N; Akashi-Takamura S; Miyake K
    Int Immunol; 2011 Aug; 23(8):503-10. PubMed ID: 21712422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.
    Rallabhandi P; Awomoyi A; Thomas KE; Phalipon A; Fujimoto Y; Fukase K; Kusumoto S; Qureshi N; Sztein MB; Vogel SN
    J Immunol; 2008 Jan; 180(2):1139-47. PubMed ID: 18178854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis).
    Wiersinga WJ; Wieland CW; Dessing MC; Chantratita N; Cheng AC; Limmathurotsakul D; Chierakul W; Leendertse M; Florquin S; de Vos AF; White N; Dondorp AM; Day NP; Peacock SJ; van der Poll T
    PLoS Med; 2007 Jul; 4(7):e248. PubMed ID: 17676990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide.
    Arranz A; Androulidaki A; Zacharioudaki V; Martinez C; Margioris AN; Gomariz RP; Tsatsanis C
    Mol Immunol; 2008 May; 45(10):2970-80. PubMed ID: 18336909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose LPS does not increase TLR4 expression on monocytes in a human in vivo model.
    Lichte P; Grigoleit JS; Steiner EM; Kullmann JS; Schedlowski M; Oberbeck R; Kobbe P
    Cytokine; 2013 Jul; 63(1):74-80. PubMed ID: 23673286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4.
    Yu X; Wang Y; Lin J; Hu Y; Kawai T; Taubman MA; Han X
    PLoS One; 2016; 11(11):e0165862. PubMed ID: 27812176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide regulation of toll-like receptor-4 and matrix metalloprotease-9 in human primary corneal fibroblasts.
    Wong Y; Sethu C; Louafi F; Hossain P
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2796-803. PubMed ID: 21220558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt expression of TLR4 in TLR4-deficient macrophages imposes a selective disadvantage: genetic evidence for TLR4-dependent responses to endogenous, nonmicrobial stimuli.
    Cohn EF; Nathan C; Radzioch D; Yu H; Xiang Z; Ding A
    J Immunol; 2006 Jan; 176(2):1185-94. PubMed ID: 16394008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide (LPS)-mediated priming of toll-like receptor 4 enhances oxidant-induced prostaglandin E
    Zhang Y; Igwe OJ
    Int Immunopharmacol; 2018 Jan; 54():226-237. PubMed ID: 29161659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 Differently Regulates Macrophage Responses to Smooth and Rough Lipopolysaccharide.
    Biedroń R; Peruń A; Józefowski S
    PLoS One; 2016; 11(4):e0153558. PubMed ID: 27073833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.
    Mancuso G; Midiri A; Biondo C; Beninati C; Gambuzza M; Macrì D; Bellantoni A; Weintraub A; Espevik T; Teti G
    Infect Immun; 2005 Sep; 73(9):5620-7. PubMed ID: 16113279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
    Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV
    Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway.
    Menon D; Coll R; O'Neill LA; Board PG
    J Cell Sci; 2015 May; 128(10):1982-90. PubMed ID: 25908843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
    Marshall JD; Heeke DS; Rao E; Maynard SK; Hornigold D; McCrae C; Fraser N; Tovchigrechko A; Yu L; Williams N; King S; Cooper ME; Hajjar AM; Woo JC
    PLoS One; 2016; 11(10):e0164632. PubMed ID: 27736941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.